Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02234713 · ClinicalTrials.gov registry record · NA

Adherence in Pediatric Multiple Sclerosis

A NA study, sponsored by The Hospital for Sick Children.

Completed
Registry status
NA
Development phase
71
Enrollment target

NCT02234713 is a NA study that has completed, run by The Hospital for Sick Children. The registered enrollment target is 71 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02234713, a NA study, has completed, sponsored by The Hospital for Sick Children.

COMPLETED
Registry status
NA
Development phase
71 participants
Enrollment target

Study Summary

Disease modifying therapies (DMT) are widely used for children and adolescents with MS. Nonetheless, many pediatric patients continue to relapse and therefore require changes in therapy. We designed this research study to learn more about medication use in children and adolescents with MS. We are also interested in learning what a behavioral feedback intervention can tell us about adherence to medicine. Finally, we hope this research project will inform the way we provide clinical care for children and adolescents with MS.

Interventions

  • BEHAVIORAL Motivational Interview
  • OTHER Video Attention Control

Trial Details

FieldValue
Enrollment Target 71 participants
Start Date 2013-01
Est. Completion 2016-09
Phase NA

Sponsor

The Hospital for Sick Children

23 total trials

What the Registry Record Tells You About NCT02234713

The ClinicalTrials.gov registry entry for NCT02234713 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 71 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The Hospital for Sick Children, which has 23 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Motivational Interview is the first listed.

NCT02234713 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT02234713 about?

NCT02234713 is a clinical study titled "Adherence in Pediatric Multiple Sclerosis". Disease modifying therapies (DMT) are widely used for children and adolescents with MS. Nonetheless, many pediatric patients continue to relapse and therefore require changes in therapy. We designed this research study to learn more about medication use in children and adolescents with MS. We are al...

What is the current status of trial NCT02234713?

This trial is currently completed. It is a NA study. The enrollment target is 71 participants. The study started on 2013-01. Estimated completion is 2016-09.

What interventions are being tested in trial NCT02234713?

The interventions under investigation include: Motivational Interview (BEHAVIORAL), Video Attention Control (OTHER).

Who is sponsoring clinical trial NCT02234713?

This trial is sponsored by The Hospital for Sick Children, which has 23 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.